Why benzodiazepines are not going away: Commentary on... Benzodiazepines for anxiety disorders

Advances in Psychiatric Treatment

Volumn 18, Issue 4, 2012, Pages 259-262

  Tyrer, Peter ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CHLORDIAZEPOXIDE; LORAZEPAM; NITRAZEPAM; TEMAZEPAM; TRIAZOLAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ANXIETY DISORDER; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENCY; DRUG TOLERANCE; DYSPHORIA; HEALTH CARE POLICY; HUMAN; LOW DRUG DOSE; NOTE; PRACTICE GUIDELINE; PRESCRIPTION; QUALITY OF LIFE; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 84864412591     PISSN: 13555146     EISSN: 14721481     Source Type: Journal    
DOI: 10.1192/apt.bp.111.009209     Document Type: Note

References (22)

1. Ashton H (1984) Benzodiazepine withdrawal: an unfinished story. BMJ 288: 1135-40.
2. Baldwin DS, Montgomery SA, Nil R, et al (2007) Discontinuation symptoms in depression and anxiety disorders. International Journal of Neuropsychopharmacology 10: 73-84.
3. Blanco C, Goodwin RD, Liebowitz MR, et al (2004) Use of psychotropic medications for patients with office visits who receive a diagnosis of panic disorder. Medical Care 42: 1242-6.
4. Burrows GD, Norman TR, Judd F, et al (1990) Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders. Journal of Psychiatric Research 24 (suppl 2): 65-72.
5. Forsyth AJ, Farquhar D, Gemmell M, et al (1993) The dual use of opioids and temazepam by drug injectors in Glasgow (Scotland). Drug and Alcohol Dependence 32: 277-80.
6. Lader M (2011) Benzodiazepines revisited - will we ever learn? Addiction 106: 2086-109.
7. Murphy SM, Owen R, Tyrer P (1989) Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone. British Journal of Psychiatry 154: 529-34.
8. Petursson H, Lader MH (1981) Withdrawal from long-term benzodiazepine treatment. BMJ 283: 643-5.
9. Price J, Cole V, Goodwin GM (2009) Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. British Journal of Psychiatry 195: 211-7.
10. Roehrs TA, Randall TA, Harris E, et al (2011) Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study. Journal of Psychopharmacology Oct 16 (epub ahead of print).
11. Starcevic V (2012) Benzodiazepines for anxiety disorders: maximising the benefits and minimising the risks. Advances in Psychiatric Treatment 18: 250-258.
12. Taylor FK (1989) The damnation of benzodiazepines. British Journal of Psychiatry 154: 697-704.
13. Tyrer P (1980) Dependence on benzodiazepines. British Journal of Psychiatry 137: 576-77.
14. Tyrer P (1993) Pharmacological differences between benzodiazepines. In Benzodiazepine Dependence (ed C Hallstrom): 221-37. Oxford University Press.
15. Tyrer P, Baldwin D (2006) Generalised anxiety disorder. Lancet 368: 2156-66.
16. Tyrer P, Rutherford D, Huggett T (1981) Benzodiazepine withdrawal symptoms and propranolol. Lancet 317: 520-2.
17. Tyrer P, Owen R, Dawling S (1983) Gradual withdrawal of diazepam after long-term therapy. Lancet 321: 1402-6.
18. Tyrer P, Seivewright N, Murphy S, et al (1988) The Nottingham study of neurotic disorder: comparison of drug and psychological treatments. Lancet 332: 235-40.
19. Tyrer P, Morgan J, Cicchetti D (2004) The Dependent Personality Questionnaire (DPQ): a screening instrument for dependent personality. International Journal of Social Psychiatry 50: 10-7.
20. Tyrer H, Tyrer P, Barrett B (2012) Influence of dependent personality on the outcome and service costs of health anxiety. International Journal of Social Psychiatry Mar 19 (epub ahead of print).
21. Uhlenhuth EH, Balter MB, Ban TA, et al (1999) International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders. Journal of Clinical Psychopharmacology 19 (suppl 2): 23S-9S.
22. Wilson SJ, Nutt DJ, Alford C, et al (2010) British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. Journal of Psychopharmacology 24: 1577-601.